Index by author

December 01, 2019; Volume 86,Issue 12

A

  1. Aronow, Benjamin

    1. Gabapentin for alcohol use disorder: A good option, or cause for concern?
      Vania Modesto-Lowe, MD, MPH, Gregory C. Barron, MD, Benjamin Aronow, BS and Margaret Chaplin, MD
      Cleveland Clinic Journal of Medicine December 2019, 86 (12) 815-823; DOI: https://doi.org/10.3949/ccjm.86a.18128

      There is concern about the potential for abuse. Use it only as a second-line alternative, with caution.

  2. Azmaiparashvili, Zurab

    1. Desquamating pustular rash
      Kevin Bryan Uy Lo, MD and Zurab Azmaiparashvili, MD
      Cleveland Clinic Journal of Medicine December 2019, 86 (12) 780-781; DOI: https://doi.org/10.3949/ccjm.86a.19061

      The symptoms had started 3 days after the patient began using ciprofl oxacin eye drops.

B

  1. Barron, Gregory C.

    1. Gabapentin for alcohol use disorder: A good option, or cause for concern?
      Vania Modesto-Lowe, MD, MPH, Gregory C. Barron, MD, Benjamin Aronow, BS and Margaret Chaplin, MD
      Cleveland Clinic Journal of Medicine December 2019, 86 (12) 815-823; DOI: https://doi.org/10.3949/ccjm.86a.18128

      There is concern about the potential for abuse. Use it only as a second-line alternative, with caution.

  2. Burke, Carol A.

    1. In reply: The authors reply
      Carol A. Burke, MD, Gautam Mankaney, MD and Richard Andrew Sutton, DO
      Cleveland Clinic Journal of Medicine December 2019, 86 (12) 776-777; DOI: https://doi.org/10.3949/ccjm.86c.12003

C

  1. Cetel, Nancy S.

    1. Colorectal cancer screening
      Joseph B. Weiss, MD, Nancy S. Cetel, MD and Danielle E. Weiss, MD
      Cleveland Clinic Journal of Medicine December 2019, 86 (12) 774-776; DOI: https://doi.org/10.3949/ccjm.86c.12002

  2. Chaplin, Margaret

    1. Gabapentin for alcohol use disorder: A good option, or cause for concern?
      Vania Modesto-Lowe, MD, MPH, Gregory C. Barron, MD, Benjamin Aronow, BS and Margaret Chaplin, MD
      Cleveland Clinic Journal of Medicine December 2019, 86 (12) 815-823; DOI: https://doi.org/10.3949/ccjm.86a.18128

      There is concern about the potential for abuse. Use it only as a second-line alternative, with caution.

D

  1. Dinardo, Perry

    1. Vaping: The new wave of nicotine addiction
      Perry Dinardo, BA and Ellen S. Rome, MD, MPH
      Cleveland Clinic Journal of Medicine December 2019, 86 (12) 789-798; DOI: https://doi.org/10.3949/ccjm.86a.19118

      Despite perceptions that vaping is harmless and claims that it can aid in smoking cessation, risks are emerging.

G

  1. Gabbard, Scott

    1. Functional heartburn: An underrecognized cause of PPI-refractory symptoms
      Functional heartburn: An underrecognized cause of PPI-refractory symptoms
      Scott Gabbard, MD and Sonya Vijayvargiya,
      Cleveland Clinic Journal of Medicine December 2019, 86 (12) 799-806; DOI: https://doi.org/10.3949/ccjm.86a.19006

      Functional heartburn is the most common cause of failure of proton pump inhibitor therapy.

  2. Goldstein, Mark R.

    1. Colorectal cancer screening
      Mark R. Goldstein, MD, FACP, Luca Mascitelli, MD and Zakia H. Rauf, MD
      Cleveland Clinic Journal of Medicine December 2019, 86 (12) 774; DOI: https://doi.org/10.3949/ccjm.86c.12001

J

  1. Jimenez, Xavier F.

    1. Beyond depression: Other uses for tricyclic antidepressants
      Joanne Schneider, DNP, RN, CNP, Mary Patterson, CNP and Xavier F. Jimenez, MD, MA
      Cleveland Clinic Journal of Medicine December 2019, 86 (12) 807-814; DOI: https://doi.org/10.3949/ccjm.86a.19005

      The pharmacology of these drugs, their potential uses in conditions other than depression, and safety considerations.

L

  1. Lo, Kevin Bryan Uy

    1. Desquamating pustular rash
      Kevin Bryan Uy Lo, MD and Zurab Azmaiparashvili, MD
      Cleveland Clinic Journal of Medicine December 2019, 86 (12) 780-781; DOI: https://doi.org/10.3949/ccjm.86a.19061

      The symptoms had started 3 days after the patient began using ciprofl oxacin eye drops.

M

  1. Mandell, Brian F.

    1. Off-label and oft-prescribed
      Brian F. Mandell, MD, PhD
      Cleveland Clinic Journal of Medicine December 2019, 86 (12) 766-767; DOI: https://doi.org/10.3949/ccjm.86b.12019

      When prescribing drugs for uses beyond their FDA indications, we need to explain their anticipated side effects and benefits.

  2. Mankaney, Gautam

    1. In reply: The authors reply
      Carol A. Burke, MD, Gautam Mankaney, MD and Richard Andrew Sutton, DO
      Cleveland Clinic Journal of Medicine December 2019, 86 (12) 776-777; DOI: https://doi.org/10.3949/ccjm.86c.12003

  3. Mascitelli, Luca

    1. Colorectal cancer screening
      Mark R. Goldstein, MD, FACP, Luca Mascitelli, MD and Zakia H. Rauf, MD
      Cleveland Clinic Journal of Medicine December 2019, 86 (12) 774; DOI: https://doi.org/10.3949/ccjm.86c.12001

  4. Modesto-Lowe, Vania

    1. Gabapentin for alcohol use disorder: A good option, or cause for concern?
      Vania Modesto-Lowe, MD, MPH, Gregory C. Barron, MD, Benjamin Aronow, BS and Margaret Chaplin, MD
      Cleveland Clinic Journal of Medicine December 2019, 86 (12) 815-823; DOI: https://doi.org/10.3949/ccjm.86a.18128

      There is concern about the potential for abuse. Use it only as a second-line alternative, with caution.

  5. Mossad, Sherif Beniameen

    1. How to respond to flu vaccine doubters
      Sherif Beniameen Mossad, MD, FACP, FIDSA, FAST
      Cleveland Clinic Journal of Medicine December 2019, 86 (12) 782-788; DOI: https://doi.org/10.3949/ccjm.86a.19139

      Misinformation and unfounded fears abound. What should you tell patients who say no to a fl u shot?

P

  1. Patterson, Mary

    1. Beyond depression: Other uses for tricyclic antidepressants
      Joanne Schneider, DNP, RN, CNP, Mary Patterson, CNP and Xavier F. Jimenez, MD, MA
      Cleveland Clinic Journal of Medicine December 2019, 86 (12) 807-814; DOI: https://doi.org/10.3949/ccjm.86a.19005

      The pharmacology of these drugs, their potential uses in conditions other than depression, and safety considerations.

R

  1. Rauf, Zakia H.

    1. Colorectal cancer screening
      Mark R. Goldstein, MD, FACP, Luca Mascitelli, MD and Zakia H. Rauf, MD
      Cleveland Clinic Journal of Medicine December 2019, 86 (12) 774; DOI: https://doi.org/10.3949/ccjm.86c.12001

  2. Rome, Ellen S.

    1. Vaping: The new wave of nicotine addiction
      Perry Dinardo, BA and Ellen S. Rome, MD, MPH
      Cleveland Clinic Journal of Medicine December 2019, 86 (12) 789-798; DOI: https://doi.org/10.3949/ccjm.86a.19118

      Despite perceptions that vaping is harmless and claims that it can aid in smoking cessation, risks are emerging.

S

  1. Schneider, Joanne

    1. Beyond depression: Other uses for tricyclic antidepressants
      Joanne Schneider, DNP, RN, CNP, Mary Patterson, CNP and Xavier F. Jimenez, MD, MA
      Cleveland Clinic Journal of Medicine December 2019, 86 (12) 807-814; DOI: https://doi.org/10.3949/ccjm.86a.19005

      The pharmacology of these drugs, their potential uses in conditions other than depression, and safety considerations.

  2. Sutton, Richard Andrew

    1. In reply: The authors reply
      Carol A. Burke, MD, Gautam Mankaney, MD and Richard Andrew Sutton, DO
      Cleveland Clinic Journal of Medicine December 2019, 86 (12) 776-777; DOI: https://doi.org/10.3949/ccjm.86c.12003

V

  1. Vijayvargiya, Sonya

    1. Functional heartburn: An underrecognized cause of PPI-refractory symptoms
      Functional heartburn: An underrecognized cause of PPI-refractory symptoms
      Scott Gabbard, MD and Sonya Vijayvargiya,
      Cleveland Clinic Journal of Medicine December 2019, 86 (12) 799-806; DOI: https://doi.org/10.3949/ccjm.86a.19006

      Functional heartburn is the most common cause of failure of proton pump inhibitor therapy.

W

  1. Weiss, Danielle E.

    1. Colorectal cancer screening
      Joseph B. Weiss, MD, Nancy S. Cetel, MD and Danielle E. Weiss, MD
      Cleveland Clinic Journal of Medicine December 2019, 86 (12) 774-776; DOI: https://doi.org/10.3949/ccjm.86c.12002

  2. Weiss, Joseph B.

    1. Colorectal cancer screening
      Joseph B. Weiss, MD, Nancy S. Cetel, MD and Danielle E. Weiss, MD
      Cleveland Clinic Journal of Medicine December 2019, 86 (12) 774-776; DOI: https://doi.org/10.3949/ccjm.86c.12002
Back to top

In this issue